Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The document concludes that developing generic topical drugs requires ensuring they match the original in quality, composition, and structure, and often involves complex testing and regulatory steps.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

Use minoxidil for hair loss treatment; assess results after 6 months.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

Liposomes improve drug delivery and reduce skin irritation in dermatology.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Fullerenes show potential in skin care but need more safety research.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

ADSC-CM treatment improved hair density and thickness in women with hair loss, safely and effectively.

Some common medications can harm male fertility, but many effects can be reversed.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Tiny needles with valproic acid can effectively regrow hair.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Squarticles effectively deliver hair growth drugs to follicles and dermal papilla cells.

Nanoparticles can enter the skin, potentially causing toxicity, especially in damaged skin.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Liposomes improve finasteride delivery for hair loss treatment, making it a promising option for topical use.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Chitosan-decorated polymersomes improve finasteride delivery for hair loss treatment.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.